Fully independent analysis confirms Sword delivers 3:1 ROI on medical spend.

• The study reports the highest medical savings in the MSK market, setting a new benchmark for cost-effectiveness.
• Performed by Risk Strategies Consulting, a recognized leader in actuarial and risk management consulting, known for rigorous and precise evaluations.

Read the report.